Treatment of Fragile X Syndrome with Cannabidiol: A Case Series Study and Brief Review of the Literature
Fragile X syndrome (FXS) is an X-linked dominant disorder caused by a mutation in the fragile X mental retardation 1 gene. Cannabidiol (CBD) is an exogenous phytocannabinoid with therapeutic potential for individuals with anxiety, poor sleep, and cognitive deficits, as well as populations with endoc...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Revisão |
| Language: | English |
| Published: |
2019
|
| Online Access: | https://doi.org/10.1089/can.2018.0053 https://www.liebertpub.com/doi/pdf/10.1089/can.2018.0053 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|